Company intelligence / Profile preview

BBCI

Schaffhauserstrasse*, Zug, Switzerlandbbci.be ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

BB Biotech AG is one of the world’s largest investors in publicly listed biotechnology companies developing innovative drugs. It focuses on firms addressing significant unmet medical needs with high growth potential. Its portfolio typically includes between 20 and 35 biotech firms at various development stages across multiple therapeutic areas. The company has over three decades of experience and targets long-term capital appreciation for its shareholders.

Therapeutic areas: OncologyMetabolic DisordersRare DiseasesImmunologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyRNA therapyCell therapyGene therapy
Industry: Investors

Beyond the preview

Go deeper on BBCI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BBCI.

Explore the full profile